Gene Logic Closes TherImmune Research Acquisition

Apr 02, 2003

NEW YORK, April 2 - Gene Logic of Gaithersburg, Md., today announced the completion of its $52 million acquisition of TherImmune Research.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.